These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 18633014)

  • 1. Thrombelastography-guided factor VIIa therapy in a surgical patient with severe hemophilia and factor VIII inhibitor.
    Pivalizza EG; Escobar MA
    Anesth Analg; 2008 Aug; 107(2):398-401. PubMed ID: 18633014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic monitoring of hemostatic management in hemophilia A patients with inhibitor in the perioperative period using rotational thromboelastometry.
    Furukawa S; Nogami K; Ogiwara K; Yada K; Minami H; Shima M
    J Thromb Haemost; 2015 Jul; 13(7):1279-84. PubMed ID: 25903848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Failure of recombinant activated factor VII during surgery in a hemophiliac with high-titer factor VIII antibody.
    Gringeri A; Santagostino E; Mannucci PM
    Haemostasis; 1991; 21(1):1-4. PubMed ID: 1907588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential role of thrombelastography in the monitoring of acquired factor VIII inhibitor hemophilia A: report on a 78-year-old woman with life-threatening bleedings.
    Spiezia L; Meneghetti L; Dalla Valle F; Tognin G; Radu C; Saggiorato G; Fadin M; Zanon E; Simioni P
    Clin Appl Thromb Hemost; 2009; 15(4):470-6. PubMed ID: 18930953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between factor VII activity and clinical efficacy of recombinant factor VIIa given by continuous infusion to patients with factor VIII inhibitors.
    Santagostino E; Morfini M; Rocino A; Baudo F; Scaraggi FA; Gringeri A
    Thromb Haemost; 2001 Oct; 86(4):954-8. PubMed ID: 11686352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical efficacy of recombinant activated factor VII (rFVIIa) during acute bleeding episode and surgery in a patient with acquired hemophilia A with high inhibitor titer.
    Franchini M; Capra F; Capelli C; de Maria E; Lippi G; Gandini G
    Haematologica; 2001 Apr; 86(4):E12. PubMed ID: 11325664
    [No Abstract]   [Full Text] [Related]  

  • 7. [Recombinant activated Factor VII (Novoseven Novo Nordisk) for hemostasis in acquired Factor VIII-inhibitor hemophilia].
    Meili EO; Dazzi H; von Felten A
    Schweiz Med Wochenschr; 1995 Mar; 125(9):405-11. PubMed ID: 7892567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombelastgram as a hemostatic monitor during recombinant factor VIIa treatment in hemophilia A patients with inhibitor to factor VIII.
    Yoshioka A; Nishio K; Shima M
    Haemostasis; 1996; 26 Suppl 1():139-42. PubMed ID: 8904189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluating and monitoring the efficacy of recombinant activated factor VIIa in patients with haemophilia and inhibitors.
    Qi X; Zhao Y; Li K; Fan L; Hua B
    Blood Coagul Fibrinolysis; 2014 Oct; 25(7):754-60. PubMed ID: 24806320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective, randomised trial of two doses of rFVIIa (NovoSeven) in haemophilia patients with inhibitors undergoing surgery.
    Shapiro AD; Gilchrist GS; Hoots WK; Cooper HA; Gastineau DA
    Thromb Haemost; 1998 Nov; 80(5):773-8. PubMed ID: 9843170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of hemophilia patients with inhibitors.
    Hedner U; Glazer S
    Hematol Oncol Clin North Am; 1992 Oct; 6(5):1035-46. PubMed ID: 1400071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful use of recombinant factor VIIa in a haemophiliac with inhibitor undergoing cataract surgery.
    Biron-Andréani C; Dupeyron G; Mainemer M; Schved JF
    Blood Coagul Fibrinolysis; 2001 Apr; 12(3):215-6. PubMed ID: 11414637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prophylactic preparation and surgical extirpation of a very large abdominal blood cyst in a severe haemophilia A patient with inhibitors managed by rFVIIa.
    Salaj P; Gurlich R; Svorcová V; Marková M; Cetkovský P
    Haemophilia; 2009 Jan; 15(1):380-2. PubMed ID: 18976250
    [No Abstract]   [Full Text] [Related]  

  • 14. Successful use of recombinant factor VIIa for emergency fasciotomy in a patient with hemophilia A and high-titer inhibitor unresponsive to factor VIII inhibitor bypassing activity.
    Watts RG
    Am J Hematol; 2005 May; 79(1):58-60. PubMed ID: 15849767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acquired hemophilia in the patient suffering from rheumatoid arthritis: case report.
    Drobiecki A; Pasiarski M; Hus I; Sokołowska B; Wątek M
    Blood Coagul Fibrinolysis; 2013 Dec; 24(8):874-80. PubMed ID: 24042266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful total hip replacement in a patient with severe haemophilia A with inhibitors using recombinant factor VIIa.
    Pasa S; Altintas A; Cil T; Danis R; Subasi M; Ayyildiz O; Muftuoglu E
    Haemophilia; 2008 Jul; 14(4):863-5. PubMed ID: 18445012
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacological concentrations of recombinant factor VIIa restore hemostasis independent of tissue factor in antibody-induced hemophilia mice.
    Keshava S; Sundaram J; Rajulapati A; Pendurthi UR; Rao LV
    J Thromb Haemost; 2016 Mar; 14(3):546-50. PubMed ID: 26727350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful use of recombinant factor VIIa for hemostasis during total knee replacement in a severe hemophiliac with high-titer factor VIII inhibitor.
    Carr ME; Loughran TP; Cardea JA; Smith WK; Kuhn JG; Dottore MV
    Int J Hematol; 2002 Jan; 75(1):95-9. PubMed ID: 11843300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of recombinant factor VIIa in the prophylaxis of bleeding in various surgical procedures in hemophilic patients with factor VIII and factor IX inhibitors.
    Ingerslev J
    Semin Thromb Hemost; 2000; 26(4):425-32. PubMed ID: 11092219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of activated recombinant human factor 7 (Niastase) on laboratory testing of inhibitors of factors VIII and IX.
    Keeney M; Allan DS; Lohmann RC; Yee IH
    Lab Hematol; 2005; 11(2):118-23. PubMed ID: 16024335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.